Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-24

Clinical Trial Update: Molecular Mechanisms of Dutasteride and Dietary Interventions to Prevent Prostate Cancer and Reduce Its Progression [NA]

View source ↗

Summary

This document summarizes an ongoing clinical trial investigating how dutasteride and dietary interventions may prevent prostate cancer and slow its progression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dutasteride (Avodart) (dutasteride)

Snippet

Sponsor: CHU de Quebec-Universite Laval | Conditions: Prostatic Neoplasms, Low Grade Prostate Cancer | NA | Status: ACTIVE_NOT_RECRUITING